Group One Trading’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-147
Closed -$29 2030
2025
Q1
$29 Sell
147
-20,368
-99% -$4.02K ﹤0.01% 1875
2024
Q4
$11.1K Sell
20,515
-27,855
-58% -$15K ﹤0.01% 1520
2024
Q3
$46K Buy
48,370
+14,333
+42% +$13.6K ﹤0.01% 1024
2024
Q2
$33.2K Buy
34,037
+11,670
+52% +$11.4K ﹤0.01% 1074
2024
Q1
$35.3K Buy
22,367
+22,316
+43,757% +$35.3K ﹤0.01% 1030
2023
Q4
$40 Buy
+51
New +$40 ﹤0.01% 1805
2023
Q3
Sell
-16,541
Closed -$15.3K 1901
2023
Q2
$15.3K Hold
16,541
﹤0.01% 1250
2023
Q1
$18K Sell
16,541
-2,491
-13% -$2.72K ﹤0.01% 1214
2022
Q4
$27.8K Sell
19,032
-2,000
-10% -$2.92K ﹤0.01% 1230
2022
Q3
$23K Buy
21,032
+2,000
+11% +$2.19K ﹤0.01% 1402
2022
Q2
$32K Sell
19,032
-3,200
-14% -$5.38K ﹤0.01% 1392
2022
Q1
$46K Buy
22,232
+326
+1% +$675 ﹤0.01% 1456
2021
Q4
$82K Buy
21,906
+15,132
+223% +$56.6K ﹤0.01% 1448
2021
Q3
$35K Sell
6,774
-44,955
-87% -$232K ﹤0.01% 1621
2021
Q2
$220K Buy
51,729
+35,672
+222% +$152K ﹤0.01% 1081
2021
Q1
$85K Buy
16,057
+15,563
+3,150% +$82.4K ﹤0.01% 1235
2020
Q4
$3K Sell
494
-121
-20% -$735 ﹤0.01% 1516
2020
Q3
$5K Sell
615
-28,006
-98% -$228K ﹤0.01% 1370
2020
Q2
$287K Buy
+28,621
New +$287K ﹤0.01% 555
2020
Q1
Hold
0
1338
2019
Q4
Hold
0
1318
2019
Q3
Hold
0
1300
2019
Q2
Sell
-6,643
Closed -$29K 1215
2019
Q1
$29K Sell
6,643
-12,882
-66% -$56.2K ﹤0.01% 844
2018
Q4
$112K Buy
19,525
+9,547
+96% +$54.8K ﹤0.01% 724
2018
Q3
$135K Buy
9,978
+7,219
+262% +$97.7K ﹤0.01% 754
2018
Q2
$33K Buy
+2,759
New +$33K ﹤0.01% 984
2018
Q1
Sell
-200
Closed -$1K 1276
2017
Q4
$1K Hold
200
﹤0.01% 1304
2017
Q3
$2K Buy
+200
New +$2K ﹤0.01% 1216
2017
Q2
Hold
0
1286
2016
Q4
Sell
-2,500
Closed -$18K 1245
2016
Q3
$18K Buy
+2,500
New +$18K ﹤0.01% 921